BACKGROUND: Radiotherapy during childhood increases long-term cancer risk, but the risk from radiation as a result of relatively higher dose diagnostic procedures remains less well known. This study, which evaluates breast cancer incidence in a cohort treated with "lower dose" chest radiotherapy over 50 years ago, can assist with estimating lifetime breast cancer risk in young children exposed to radiation from procedures such as chest computed tomography (CT) or treatment with recent "lower dose" chest radiotherapy protocols. METHODS: A population-based, longitudinal cohort of subjects exposed to thymic irradiation during infancy from 1926 to 1957 and of their unexposed siblings was re-established. Previously followed until 1987, we resurveyed cohort members from 2004 to 2008. Poisson regression models compared breast cancer incidence rates between women in the cohort by treatment and dose category groups. RESULTS: Breast cancer occurred in 96 treated (mean breast dose, 0.71 Gy) and 57 untreated women during 159,459 person-years of follow-up. After adjusting for attained age and treatment/birth cohort, the rate ratio was 3.01 (2.18-4.21). The adjusted excess relative risk per Gy was 1.10 (95% confidence interval, 0.61-1.86). Traditional breast cancer risk factors did not contribute significantly to multivariate model fit. CONCLUSION: Our results show that at radiation doses between those received by the breast from chest CT and cancer therapy during early childhood, breast cancer incidence rates remain elevated >50 years after exposure. This implies that increased breast cancer risk will remain a lifelong concern in females treated during childhood with currently reduced radiotherapy doses and for infants receiving multiple chest CTs.
BACKGROUND: Radiotherapy during childhood increases long-term cancer risk, but the risk from radiation as a result of relatively higher dose diagnostic procedures remains less well known. This study, which evaluates breast cancer incidence in a cohort treated with "lower dose" chest radiotherapy over 50 years ago, can assist with estimating lifetime breast cancer risk in young children exposed to radiation from procedures such as chest computed tomography (CT) or treatment with recent "lower dose" chest radiotherapy protocols. METHODS: A population-based, longitudinal cohort of subjects exposed to thymic irradiation during infancy from 1926 to 1957 and of their unexposed siblings was re-established. Previously followed until 1987, we resurveyed cohort members from 2004 to 2008. Poisson regression models compared breast cancer incidence rates between women in the cohort by treatment and dose category groups. RESULTS:Breast cancer occurred in 96 treated (mean breast dose, 0.71 Gy) and 57 untreated women during 159,459 person-years of follow-up. After adjusting for attained age and treatment/birth cohort, the rate ratio was 3.01 (2.18-4.21). The adjusted excess relative risk per Gy was 1.10 (95% confidence interval, 0.61-1.86). Traditional breast cancer risk factors did not contribute significantly to multivariate model fit. CONCLUSION: Our results show that at radiation doses between those received by the breast from chest CT and cancer therapy during early childhood, breast cancer incidence rates remain elevated >50 years after exposure. This implies that increased breast cancer risk will remain a lifelong concern in females treated during childhood with currently reduced radiotherapy doses and for infants receiving multiple chest CTs.
Authors: Lois B Travis; Deirdre Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Eero Pukkala; Charles F Lynch; David Pee; Susan A Smith; Mars B Van't Veer; Timo Joensuu; Hans Storm; Marilyn Stovall; John D Boice; Ethel Gilbert; Mitchell H Gail Journal: J Natl Cancer Inst Date: 2005-10-05 Impact factor: 13.506
Authors: Deirdre A Hill; Ethel Gilbert; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars Van't Veer; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle E Curtis; James M Allan; John D Boice; Lois B Travis Journal: Blood Date: 2005-07-28 Impact factor: 22.113
Authors: F E van Leeuwen; W J Klokman; A Hagenbeek; R Noyon; A W van den Belt-Dusebout; E H van Kerkhoff; P van Heerde; R Somers Journal: J Clin Oncol Date: 1994-02 Impact factor: 44.544
Authors: Sabha Bhatti; Robert C Hendel; Juan Lopez-Mattei; Ronald G Schwartz; Gilbert Raff; Andrew J Einstein Journal: J Nucl Cardiol Date: 2016-06-06 Impact factor: 5.952
Authors: Michael Jacob Adams; Roy E Shore; Ann Dozier; Steven E Lipshultz; Ronald G Schwartz; Louis S Constine; Thomas A Pearson; Marilyn Stovall; Kelly Thevenet-Morrison; Susan G Fisher Journal: Radiat Res Date: 2010-10-26 Impact factor: 2.841
Authors: Stephen S Yoo; Timothy J Jorgensen; Ann R Kennedy; John D Boice; Alla Shapiro; Tom C-C Hu; Brian R Moyer; Marcy B Grace; Gary J Kelloff; Michael Fenech; Pataje G S Prasanna; C Norman Coleman Journal: J Radiol Prot Date: 2014-04-14 Impact factor: 1.394
Authors: M P Little; M L Schaeffer; R C Reulen; D H Abramson; M Stovall; R Weathers; F de Vathaire; I Diallo; J M Seddon; M M Hawkins; M A Tucker; R A Kleinerman Journal: Br J Cancer Date: 2014-04-22 Impact factor: 7.640
Authors: Michael Jacob Adams; Susan G Fisher; Steven E Lipshultz; Roy E Shore; Louis S Constine; Marilyn Stovall; Ann Dozier; Kelly Thevenet-Morrison; Robert Block; Ronald G Schwartz; Thomas A Pearson Journal: Cardiooncology Date: 2018-02-17